Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

IPO Update: Three More Biotechs Squeeze Through The Window

Executive Summary

What's the best metaphor for the past two weeks of US biotechnology initial public offerings? That would be a sharp intake of air through the teeth – the sound you make when you see someone do something really painful.


Related Content

Half of 2016 Biotech IPOs Positive At Mid-Year; 2015 Success Rate Sours
IPO Update: Haircuts Needed To Price Biotech Offerings
IPO Update: Intellia Launch Shows CRISPR Still Excites While Others Struggle
Partners hit as Reata ends PhIII BEACON trial with bardoxolone in CKD


Related Companies